AGREEMENT AND PLAN OF MERGER AND REORGANIZATION AMONG ADVAXIS, INC., ADVAXIS LTD., AND BIOSIGHT LTD. DATED AS OF JULY 4, 2021Merger Agreement • July 6th, 2021 • Advaxis, Inc. • Pharmaceutical preparations • Delaware
This Agreement and Plan of Merger and reorganization (this “Agreement”) is made and entered into as of July 4, 2021, by and among Advaxis, Inc., a Delaware corporation (“Advaxis”), Advaxis Ltd., a company organized under the laws of the State of Israel and a wholly owned Subsidiary of Advaxis (“Merger Sub”), and Biosight Ltd., a company organized under the laws of the State of Israel (“Biosight”). Advaxis, Merger Sub and Biosight are referred to individually as a “Party” and collectively as the “Parties”. Certain capitalized terms used in this Agreement are defined in Exhibit A.
SUPPORT AGREEMENTSupport Agreement • July 6th, 2021 • Advaxis, Inc. • Pharmaceutical preparations • Delaware
This Support Agreement (this “Agreement”), dated as of July 4, 2021, is entered into by and among Advaxis, Inc., a Delaware corporation (“Advaxis”), Biosight Ltd., a company organized under the laws of the State of Israel (“Biosight”) and the director or executive officer of Advaxis included on the signature page hereto (“Stockholder”). Defined terms used but not defined herein shall have the meaning ascribed to such terms in the Merger Agreement (as defined below).
